Although the medical relevance on the aforementioned cardiovascular risk factor alterations by tirzepatide will likely be assessed within the prepared cardiovascular outcome examine SURPASS-CVOT ( "type":"medical-trial","attrs": "text":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Investigation indicated th… Read More